Boston Partners Sells 1,107,734 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Boston Partners decreased its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 66.7% in the second quarter, HoldingsChannel.com reports. The institutional investor owned 554,279 shares of the company’s stock after selling 1,107,734 shares during the quarter. Boston Partners’ holdings in Henry Schein were worth $38,751,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of HSIC. Ibex Wealth Advisors purchased a new position in Henry Schein in the second quarter worth $40,000. Janney Montgomery Scott LLC grew its holdings in shares of Henry Schein by 89.7% during the second quarter. Janney Montgomery Scott LLC now owns 24,882 shares of the company’s stock valued at $1,739,000 after buying an additional 11,768 shares during the last quarter. Toronto Dominion Bank grew its holdings in shares of Henry Schein by 0.5% during the second quarter. Toronto Dominion Bank now owns 106,298 shares of the company’s stock valued at $7,428,000 after buying an additional 548 shares during the last quarter. Tyers Asset Management LLC lifted its position in Henry Schein by 6.7% during the first quarter. Tyers Asset Management LLC now owns 59,584 shares of the company’s stock valued at $3,582,000 after purchasing an additional 3,744 shares during the period. Finally, Clal Insurance Enterprises Holdings Ltd acquired a new position in Henry Schein during the first quarter valued at $1,202,000.

HSIC has been the subject of a number of research reports. Barrington Research restated a “buy” rating and set a $75.00 target price on shares of Henry Schein in a research report on Wednesday, August 7th. Wolfe Research initiated coverage on shares of Henry Schein in a research report on Thursday, May 30th. They set an “underperform” rating for the company. TheStreet downgraded shares of Henry Schein from a “b” rating to a “c+” rating in a research report on Friday, August 30th. Zacks Investment Research downgraded shares of Henry Schein from a “buy” rating to a “hold” rating and set a $76.00 target price for the company. in a research report on Wednesday, June 19th. Finally, William Blair downgraded shares of Henry Schein from an “outperform” rating to a “market perform” rating in a research report on Wednesday, August 7th. Six analysts have rated the stock with a sell rating, ten have given a hold rating and four have issued a buy rating to the company’s stock. Henry Schein presently has an average rating of “Hold” and an average target price of $73.64.



In other Henry Schein news, Vice Chairman James P. Breslawski sold 6,856 shares of the company’s stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $60.17, for a total value of $412,525.52. Following the completion of the transaction, the insider now owns 249,046 shares in the company, valued at $14,985,097.82. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 1.06% of the company’s stock.

Shares of Henry Schein stock traded up $0.60 during trading hours on Thursday, reaching $63.47. The stock had a trading volume of 12,941 shares, compared to its average volume of 1,081,365. The stock’s 50 day moving average is $62.64 and its 200 day moving average is $64.62. The firm has a market capitalization of $9.65 billion, a PE ratio of 15.39, a PEG ratio of 2.52 and a beta of 0.86. Henry Schein, Inc. has a twelve month low of $56.58 and a twelve month high of $72.81. The company has a current ratio of 1.70, a quick ratio of 0.95 and a debt-to-equity ratio of 0.33.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $0.84 earnings per share for the quarter, topping analysts’ consensus estimates of $0.83 by $0.01. The business had revenue of $2.45 billion during the quarter, compared to the consensus estimate of $2.48 billion. Henry Schein had a net margin of 4.18% and a return on equity of 16.67%. The company’s revenue was up 5.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.04 earnings per share. As a group, sell-side analysts predict that Henry Schein, Inc. will post 3.46 earnings per share for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Featured Story: Coverage Ratio

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.